Admin, Author at CereVasc | Neurological Disease Device Company | Page 2 of 3

About Admin

This author has not yet filled in any details.
So far Admin has created 22 blog entries.

04 May, 2023

CereVasc to Present Data on its Minimally Invasive CNS Delivery System at Upcoming American Society of Gene and Cell Therapy Annual Meeting

Admin2023-11-06T22:08:22+00:00May 4th, 2023|

28 Mar, 2023

CereVasc Appoints Dr. Adel Malek Chief Medical Officer

Admin2023-11-06T22:03:27+00:00March 28th, 2023|

21 Nov, 2022

Tufts Medical Center Neurosurgeons and CereVasc Co-founders Honored by the Society of Vascular and Interventional Neurology for Innovation in Hydrocephalus Treatment

Admin2023-11-06T21:59:07+00:00November 21st, 2022|

29 Aug, 2022

CereVasc Announces First Patient Treated in U.S. Pilot Trial Evaluating the eShunt System in Patients with Normal Pressure Hydrocephalus

Admin2023-11-06T21:52:45+00:00August 29th, 2022|

09 Aug, 2022

CereVasc Announces FDA Approval of Second IDE Study of the eShunt® System

Admin2023-11-06T21:48:30+00:00August 9th, 2022|

25 Apr, 2022

First patient treated in CereVasc® clinical trial of eShunt® System for Normal Pressure Hydrocephalus

Admin2023-11-06T21:37:10+00:00April 25th, 2022|

08 Feb, 2022

CereVasc Receives FDA IDE Approval to Begin Initial Clinical Study of the eShunt® System for Patients with Normal Pressure Hydrocephalus

Admin2023-11-06T21:21:09+00:00February 8th, 2022|

07 Dec, 2021

CereVasc Announces Publication of First-in-Human Case Report of its eShunt System for the Treatment of Communicating Hydrocephalus

Admin2023-11-06T21:13:31+00:00December 7th, 2021|

03 Dec, 2021

First-in-human endovascular treatment of hydrocephalus with a miniature biomimetic transdural shunt

Admin2024-10-15T17:38:26+00:00December 3rd, 2021|Tags: Journal of NeuroInterventional Surgery|

08 Apr, 2021

Case 10-2021: A 70-Year-Old Man with Depressed Mood, Unsteady Gait, and Urinary Incontinence

Admin2023-12-19T22:48:26+00:00April 8th, 2021|